Generics

What to watch—and watch out for—in the bottom half of '07

...90% of respondents currently use strategies that encourage the use of mail order and 38% have rules that require it.

The US patent for Lipitor is not due to expire until March 2010, but Ranbaxy had sought to market a generic version prior to that date. The Supreme Court's action shuts the door on that effort.

Large increases in prescriptions for and sales of generics and biologics were the major stories for the US pharmaceutical industry in 2006.

Generic Pharmaceutical Association: www.gphaonline.org

The Waxman-Hatch law is said to have given birth to the modern generic drug industry in the United States

All approved drugs, both innovator and generic, are listed in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book).

Dynamic Changes Require Informed Decision Making

By going direct-to-consumer, the industry unwittingly unleashed a swarm of opportunities for other players to enter the pharmaceutical fray.

The number of Medicare Part D subscribers who fall into the coverage gap looks smaller than was feared. Will that fact fall into the gap inside the Beltway?